Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Verotoxins (VT) are a family of Escherichia coli-derived toxins which have been associated with hemolytic uremic syndrome, the leading cause of acute pediatric renal failure, and hemorrhagic colitis. Verotoxins (VT1 and VT2c) both show terminal gal alpha 1-4gal-dependent binding to globotriaosylceramide (Gal alpha 1-4Gal beta 1-4Glc-Cer; Gb3), yet VT2c shows a thousandfold lower specific cytotoxic activity in vitro. Our previous studies have shown this discrepancy is a function of the receptor binding B subunit and that VT1/Gb3 binding in a lipid matrix is affected by heterogeneity in the ceramide fatty acid chain length. The influence of the fatty acid composition of Gb3 on the binding of VT1 and VT2c has now been compared using 14 homogeneous semisynthetic Gb3 molecular species of differing fatty acid chain length and degree of saturation from C12 to C24. The binding of verotoxin was quantitated by Scatchard analysis using a solid-phase binding assay in the presence of auxiliary lipids, which may in some respects approximate to receptor function within the plasma membrane of sensitive cells. Differential binding was observed for several of these species in the lipid matrix, indicating that the fatty acid moiety of Gb3 is important for VT binding under such conditions. The short chain fatty acid containing Gb3 (C12 and C14) showed minimal binding. Middle and long chain fatty acid Gb3 homologues (C16, C18, C20, C22, and C24) were effectively recognized by VTs. The presence of an unsaturated fatty acid in Gb3 significantly increased VT binding in all cases. C20:0 and C22:1 containing Gb3 had the greatest capacity to bind VT1. In contrast, C18:0 and C18:1 homologues showed the greatest capacity for VT2c binding (higher than VT1). These results were, in general, reflected in cell cytotoxicity in that receptor-deficient cells reconstituted with C22:1Gb3 were maximally sensitive to VT1 in vitro whereas cells reconstituted with C18:1Gb3 were maximally sensitive to VT2c. VT2c was an ineffective inhibitor of 125I-VT1 binding to C22:1 Gb3 but in contrast, more effective than VT1 to compete binding to C18:1 Gb3. Similarly, VT1 was less effective than VT2c to compete binding of 125I-VT2c to C18:1 but more effective than VT2c to compete for C22:1 Gb3 binding. These results suggest that VT1 and VT2c bind selectively to different but overlapping carbohydrate epitopes on the Gb3 molecule which are differentially available in these Gb3 fatty acid homologues in a lipid environment.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Hemorrhagic Colitis Associated with a Rare Escherichia coli Serotype
Riley, L. W., Remis, R. S., Helgerson, S. D., McGee, H. B., Wells, J. G., Davis, B. R., Hebert, R. J., Olcott, E. S., Johnson, L. M., Hargrett, N. T., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303243081203 · Cited by 2,668
Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S., & Lior, H. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.5.775 · Cited by 1,388
Infection by verocytotoxin-producing Escherichia coli
Karmali, M. A. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.1.15 · Cited by 1,322
(1966) · Index to Reviews, Symposia Volumes and Monographs in Organic Chemistry · doi:10.1016/b978-0-08-012210-6.50017-x · Cited by 1,190
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
Brown, K. E., Anderson, S. M., & Young, N. S. (1993) · Science · doi:10.1126/science.8211117 · Cited by 856
O’Brien, A. D., & Holmes, R. K. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.2.206-220.1987 · Cited by 727
Strockbine, N. A., Marques, L. R., Newland, J. W., Smith, H. W., Holmes, R. K., & O'Brien, A. D. (1986) · Infection and Immunity · doi:10.1128/iai.53.1.135-140.1986 · Cited by 560
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
Lingwood, C. A., Law, H., Richardson, S., Petric, M., Brunton, J. L., De Grandis, S., & Karmali, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47490-x · Cited by 463
Self-citationJackson, M. (1987) · FEMS Microbiology Letters · doi:10.1016/0378-1097(87)90210-2 · Cited by 388
Research works printed but not linked: 9
- O'Brien, 1987, Microbiol. Rev., 51, 206, 10.1128/mr.51.2.206-220.1987 · doi:10.1128/mr.51.2.206-220.1987 · Paper page
- Marques, 1987, FEMS Microbiol. Lett., 44, 33, 10.1111/j.1574-6968.1987.tb02237.x · doi:10.1111/j.1574-6968.1987.tb02237.x · Paper page
- Mangeney, 1993, Cancer Res., 53, 5314
- Jackson, 1987, FEMS Microbiol. Lett., 44, 109, 10.1111/j.1574-6968.1987.tb02252.x · doi:10.1111/j.1574-6968.1987.tb02252.x · Paper page
- Zoja, 1992, J. Lab. Clin. Med., 120, 229
- Head, 1988, FEMS Microbiol. Lett., 51, 211, 10.1111/j.1574-6968.1988.tb02999.x · doi:10.1111/j.1574-6968.1988.tb02999.x · Paper page
- Lingwood, 1991, Adv. Lipid Res., 1, 39
- Kannagi, 1983, Cancer Res., 43, 4997
- Saitoh, 1992, Eur. J. Gastroenterol. Hepatol., 4, S49
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
Paton, J. C., & Paton, A. W. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.450 · Cited by 1,449
Shiga toxin-producing Escherichia coli: An overview1
Gyles, C. L. (2007) · Journal of Animal Science · doi:10.2527/jas.2006-508 · Cited by 849
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
Shiga Toxin (Stx) Classification, Structure, and Function
Melton-Celsa, A. R. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0024-2013 · Cited by 525
Metadata
- Authors
- Kiarash, A., Boyd, B., & Lingwood, C. A.
- Affiliations
- University of Toronto (CA)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1994-04
- Volume
- 269
- Issue
- 15
- Pages
- 11138-11146
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1532731856
- Cited by
- 206
- References
- 74
- Citations by year
- 2023: 3 · 2022: 6 · 2021: 5 · 2020: 11 · 2019: 4 · 2017: 8 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 5 · 2012: 3
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 9710 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Toxin Mechanisms and Immunotoxins
- Keywords
- Shiga toxin, globotriaosylceramide, Gb3 receptor, glycosphingolipid receptors, fatty acid chain length, unsaturated fatty acids, receptor binding, hemolytic uremic syndrome, Escherichia coli toxins, cytotoxicity, lipid matrix, hemagglutination inhibition
- MeSH terms
- Bacterial Toxins, Binding, Competitive, Cell Line, Cell Survival, Enterotoxins, Escherichia coli, Fatty Acids, Humans, Kidney, Kinetics, Receptors, Cell Surface, Structure-Activity Relationship, Trihexosylceramides, Tumor Cells, Cultured, Shiga Toxin 1, Shiga Toxin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. https://app.cochat.ai/papers/10.1016/s0021-9258(19)78102-2
- The paper
- Kiarash, A., Boyd, B., & Lingwood, C. A. (1994). Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)78102-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.